pharmaphorum.com
EU expands use of Roche's new haemophilia A drug - Pharmaphorum
The European Commission has approved Roche haemophilia A drug Hemlibra, for patients without factor VIII inhibitors, expanding the use of the drug that is expected to drive sales as blockbuster cancer drugs go off patent.